David Uffer is a widely recognized and connected medtech insider. He will attend the 2021 Emerging Medtech Summit to represent Alira Health's extensive advisory services and to network with other industry insiders and company CEOs. Uffer will moderate a panel on the topic of strategic deal-making and corporate partnering.
Uffer has over 25 years of management experience in clinical diagnostics, product development, and the medical device industry. His focus on strategy, planning, and business development allows him to provide comprehensive solutions to clients. David has worked with global mid- and large-cap companies across the U.S., Europe, and Asia.
CEO, Founder, and proud member and connector in the Medtech ecosystem. As CEO of LSI, a global healthcare market research and advisory firm, I support startups, investors, strategics, and professional service companies by providing independent market data/insights to help inform their decisions. I aim to leverage my deep network to connect investors with innovators tackling the world's biggest healthcare challenges. Proud to be the Founder of the US and European Emerging Medtech Summit events which have become the go-to investment & partnering conferences in Medtech. I've managed over 200 consulting and due diligence engagements with companies such as J&J, Medtronic, Abbott, Siemens Healthineers, General Electric, amongst others. Proud and honored to serve as a Board Advisor to several early/growth-stage companies and to advise private investors, family offices, PE firms, and SPACs to identify new opportunities in healthcare.
CEO, Founder, and proud member and connector in the Medtech ecosystem. As CEO of LSI, a global healthcare market research and advisory firm, I support startups, investors, strategics, and professional service companies by providing independent market data/insights to help inform their decisions. I aim to leverage my deep network to connect investors with innovators tackling the world's biggest healthcare challenges. Proud to be the Founder of the US and European Emerging Medtech Summit events which have become the go-to investment & partnering conferences in Medtech. I've managed over 200 consulting and due diligence engagements with companies such as J&J, Medtronic, Abbott, Siemens Healthineers, General Electric, amongst others. Proud and honored to serve as a Board Advisor to several early/growth-stage companies and to advise private investors, family offices, PE firms, and SPACs to identify new opportunities in healthcare.
Specialties: Business Development, M&A, Strategic Planning and Corporate Strategy, Strategic Marketing, Medical Technology and Startup Assessment and Evaluation, Due Diligence, Integration, Licensing and Partnering
Specialties: Business Development, M&A, Strategic Planning and Corporate Strategy, Strategic Marketing, Medical Technology and Startup Assessment and Evaluation, Due Diligence, Integration, Licensing and Partnering
David Uffer is a widely recognized and connected medtech insider. He will attend the 2021 Emerging Medtech Summit to represent Alira Health's extensive advisory services and to network with other industry insiders and company CEOs. Uffer will moderate a panel on the topic of strategic deal-making and corporate partnering.
Uffer has over 25 years of management experience in clinical diagnostics, product development, and the medical device industry. His focus on strategy, planning, and business development allows him to provide comprehensive solutions to clients. David has worked with global mid- and large-cap companies across the U.S., Europe, and Asia.
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy